The “Albumin Italian Outcome Sepsis” (ALBIOS) trial investigated 20% albumin with crystalloids versus crystalloids alone in patients with sepsis or septic shock, showing similar 90-day survival rates [66]. This evidence concerns the gene ALB and Sepsis.